Oral Temozolamide concurrent with radical radiotherapy for patients with glioblastoma multiforme: The University Hospitals of Leicester Experience

被引：0
|
作者：
Gore, A. [1 ]
Boiangiu, I. [1 ]
Symonds, R. P. [1 ]
机构：
[1] Univ Leicester Hosp NHS Trust, Dept Oncol, Leicester LE1 7RH, Leics, England
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70923-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2520
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [31] Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme
    Klautke, G.
    Schuetze, M.
    Bomber, I.
    Benecke, R.
    Piek, J.
    Fietkau, R.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (02) : 199 - 205
  • [32] Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme
    G. Klautke
    M. Schütze
    I. Bombor
    R. Benecke
    J. Piek
    R. Fietkau
    [J]. Journal of Neuro-Oncology, 2006, 77 : 199 - 205
  • [33] Toxicity of concurrent and adjuvant temozolomide in patients with glioblastoma multiforme (GBM).
    Mcmahon, David
    Hussein, Awab
    Mangleburg, Hunter
    Nichianain, Aine
    Fitzpatrick, Orla
    McLaughlin, Ronan Andrew
    Conroy, Michael R.
    Marks, Sam Jonathan
    Naidoo, Jarushka
    Grogan, William
    Murphy, Adrian Gerard
    Breathnach, Oscar S.
    Hennessy, Bryan T.
    Morris, Patrick G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] RADIATION THERAPY (RT) AND TEMOZOLAMIDE (TMZ) AS ADJUVANT THERAPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM). PRELIMINARY DATA
    Iodice, G.
    Fusco, V.
    Tartarone, A.
    Bochicchio, A. M.
    Capobianco, A.
    Coccaro, M. R.
    Di Leo, P.
    Romano, G. P.
    Castaldo, G.
    Montagna, A.
    Lapadula, L.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 87 - 87
  • [35] Accelerated hypofractionated intensity modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: A safety and efficacy analysis
    Panet-Raymond, V.
    Roberge, D.
    Sonhami, L.
    Shakibnia, L.
    Kavan, P.
    Muanza, T.
    Lambert, C.
    Guiot, M. C.
    Shenouda, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S245 - S246
  • [36] Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme
    Wolff, JEA
    Mölenkamp, G
    Westphal, S
    Pietsch, T
    Gnekow, A
    Kortmann, RD
    Kuehl, J
    [J]. CANCER, 2000, 89 (10) : 2131 - 2137
  • [37] Long-term survivors with glioblastoma multiforme after concurrent temozolomide (TMZ) and radiotherapy
    Micke, O
    Schäfer, U
    Schüller, P
    Willich, N
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 45 - 45
  • [38] Recurrent glioblastoma multiforme: Potential benefits using fractionated stereotactic radiotherapy and concurrent Taxol
    Lederman, G
    Arbit, E
    Odaimi, M
    Wertheim, S
    Lombardi, E
    [J]. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 1997, 69 (1-4) : 162 - 174
  • [39] Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolamide for glioblastoma in good performance status elderly patients early results of a phase II trial
    Floyd, Scott R.
    Kasper, Ekkehard M.
    Uhlmann, Erik J.
    Fonkem, Ekokobe
    Wong, Eric T.
    Mahadevan, Anand
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [40] Hypofractionated radiotherapy versus conventional fractionated radiotherapy in elderly patients with glioblastoma multiforme
    El-Shenshawy, H. M.
    El-Razek, A. Abd
    Bader, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345